High glucose induces plasminogen activator inhibitor-1 expression through Rho/Rho-kinase-mediated NF-κB activation in bovine aortic endothelial cells

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 22-28

  Iwasaki, Hitoshi ^a   Okamoto, Ryuji ^a   Kato, Shinya ^a   Konishi, Katsuhisa ^a   Mizutani, Hideo ^a   Yamada, Norikazu ^a   Isaka, Naoki ^a   Nakano, Takeshi ^a   Ito, Masaaki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial cells; Hyperglycemia; NF B; PAI 1; Rho Rho kinase

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PARTHENOLIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; RHO KINASE INHIBITOR; SN 50;

ANIMAL CELL; AORTA; ARTICLE; CONTROLLED STUDY; COW; DRUG INHIBITION; ENDOTHELIUM CELL; HYPERGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; AORTA, THORACIC; CATTLE; CELLS, CULTURED; CULTURE MEDIA; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; NF-KAPPA B; PLASMINOGEN ACTIVATOR INHIBITOR 1; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 38049084708     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.12.025     Document Type: Article

References (33)

1. Hoekstra T., Geleijnse J.M., Schouten E.G., et al. Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thromb Haemost 91 (2004) 861-872
2. Sobel B.E., Woodcock-Mitchell J., Schneider D.J., et al. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence. Circulation 97 (1998) 2213-2221
3. Dandona P., Aljada A., Chaudhuri A., et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005) 1448-1454
4. Collins T., and Cybulsky M.I. NF-κB: pivotal mediator or innocent bystander in atherogenesis?. J Clin Invest 107 (2001) 255-264
5. Pieper G.M., and Riaz-ul-Haq. Activation of nuclear factor-κB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol 30 (1997) 528-532
6. Hamuro M., Polan J., Natarajan M., et al. High glucose-induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis 162 (2002) 277-287
7. Ha H., Yu M.R., Choi Y.J., et al. Role of high glucose-induced nuclear factor-κB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13 (2002) 894-902
8. Yerneni K.K., Bai W., Khan B.V., et al. Hyperglycemia-induced activation of nuclear transcription factor κB in vascular smooth muscle cells. Diabetes 48 (1999) 855-864
9. Devaraj S., Venugopal S.K., Singh U., et al. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-α and -β. Diabetes 54 (2005) 85-91
10. Rolfe B.E., Worth N.F., World C.J., et al. Rho and vascular disease. Atherosclerosis 183 (2005) 1-16
11. Nakakuki T., Ito M., Iwasaki H., et al. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 25 (2005) 2088-2093
12. Rikitake Y., and Liao J.K. Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation 111 (2005) 3261-3268
13. Hehner S.P., Heinrich M., Bork P.M., et al. Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β. J Biol Chem 273 (1998) 1288-1297
14. Pierce J.W., Schoenleber R., Jesmok G., et al. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272 (1997) 21096-21103
15. Lin Y.Z., Yao S.Y., Veach R.A., et al. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270 (1995) 14255-14258
16. Sill H., Butler C., Theodore M., et al. Albumin permeability and electrical resistance as means of assessing endothelial monolayer integrity in vitro. Methods Cell Sci 14 (1992) 253-257
17. Ren X.D., Kiosses W.B., and Schwartz M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 18 (1999) 578-585
18. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
19. Moreno P.R., and Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 44 (2004) 2293-2300
20. Vaughan D.E. PAI-1 and atherothrombosis. J Thromb Haemost 3 (2005) 1879-1883
21. Danesh F.R., Sadeghi M.M., Amro N., et al. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: implications for diabetic nephropathy. Proc Natl Acad Sci U S A 99 (2002) 8301-8305
22. Mehta D., Rahman A., and Malik A.B. Protein kinase C-α signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem 276 (2001) 22614-22620
23. Lee T.S., Saltsman K.A., Ohashi H., et al. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A 86 (1989) 5141-5145
24. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
25. Bailey S.R., Mitra S., Flavahan S., et al. Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 289 (2005) H243-H250
26. Lee E.A., Seo J.Y., Jiang Z., et al. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney Int 67 (2005) 1762-1771
27. Inoguchi T., Sonta T., Tsubouchi H., et al. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 14 (2003) S227-S232
28. Kawamura H., Yokote K., Asaumi S., et al. High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 24 (2004) 276-281
29. Hill C.S., Wynne J., and Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81 (1995) 1159-1170
30. Marinissen M.J., Chiariello M., Tanos T., et al. The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell 14 (2004) 29-41
31. Hodge J.C., Bub J., Kaul S., et al. Requirement of RhoA activity for increased nuclear factor κB activity and PC-3 human prostate cancer cell invasion. Cancer Res 63 (2003) 1359-1364
32. Segain J.P., Raingeard de la Bletiere D., Sauzeau V., et al. Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology 124 (2003) 1180-1187
33. Hou B., Eren M., Painter C.A., et al. Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappa B site. J Biol Chem 279 (2004) 18127-18136